首页> 外文期刊>Cell >Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells
【24h】

Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells

机译:TRNA衍生的片段的假染蛋白在干细胞中的转化控制

获取原文
获取原文并翻译 | 示例
       

摘要

Pseudouridylation (J) is the most abundant and widespread type of RNA epigenetic modification in living organisms; however, the biological role of J remains poorly understood. Here, we show that a J-driven posttranscriptional program steers translation control to impact stem cell commitment during early embryogenesis. Mechanistically, the J "writer'' PUS7 modifies and activates a novel network of tRNA-derived small fragments (tRFs) targeting the translation initiation complex. PUS7 inactivation in embryonic stem cells impairs tRF-mediated translation regulation, leading to increased protein biosynthesis and defective germ layer specification. Remarkably, dysregulation of this posttranscriptional regulatory circuitry impairs hematopoietic stem cell commitment and is common to aggressive subtypes of human myelodysplastic syndromes. Our findings unveil a critical function of J in directing translation control in stem cells with important implications for development and disease.
机译:假染蛋白(J)是生物体中最丰富和广泛的RNA表观遗传改性; 然而,j的生物学作用仍然清晰。 在这里,我们表明,J驱动的后术后计划Steers翻译控制在早期胚胎发生期间冲击干细胞承诺。 机械地,J“作者”的PUS7改变并激活靶向翻译起始复合物的TRNA衍生的小片段(TRFS)的新型网络。PUS7在胚胎干细胞中的失活损害TRF介导的翻译调节,导致蛋白质生物合成和有缺陷的蛋白质 胚芽层规范。显着的是,这种前术治疗电路的失调危及造血干细胞承诺,对人肌细胞增强症的侵袭性亚型是常见的。我们的研究结果揭示了J在干细胞中引导对照控制的临界功能,具有对发展和疾病的重要意义。 。

著录项

  • 来源
    《Cell》 |2018年第5期|共39页
  • 作者单位

    Lund Univ Div Mol Hematol Dept Lab Med Lund Stem Cell Ctr Fac Med Lund Sweden;

    Lund Univ Div Mol Hematol Dept Lab Med Lund Stem Cell Ctr Fac Med Lund Sweden;

    Lund Univ Div Mol Hematol Dept Lab Med Lund Stem Cell Ctr Fac Med Lund Sweden;

    Lund Univ Div Mol Hematol Dept Lab Med Lund Stem Cell Ctr Fac Med Lund Sweden;

    Univ Washington Fred Hutchinson Canc Res Ctr Div Human Biol Dept Med Seattle WA 98195 USA;

    Karolinska Inst Dept Med Ctr Hematol &

    Regenerat Med Stockholm Sweden;

    Lund Univ Div Mol Hematol Dept Lab Med Lund Stem Cell Ctr Fac Med Lund Sweden;

    Lund Univ Div Mol Hematol Dept Lab Med Lund Stem Cell Ctr Fac Med Lund Sweden;

    Lund Univ Div Mol Hematol Dept Lab Med Lund Stem Cell Ctr Fac Med Lund Sweden;

    Univ Copenhagen Biotech Res &

    Innovat Ctr Copenhagen Denmark;

    Univ Washington Fred Hutchinson Canc Res Ctr Div Human Biol Dept Med Seattle WA 98195 USA;

    Linkoping Univ Dept Clin &

    Expt Med Linkoping Sweden;

    Lund Univ Div Mol Hematol Dept Lab Med Lund Stem Cell Ctr Fac Med Lund Sweden;

    Lund Univ Div Mol Hematol Dept Lab Med Lund Stem Cell Ctr Fac Med Lund Sweden;

    Lund Univ Div Mol Hematol Dept Lab Med Lund Stem Cell Ctr Fac Med Lund Sweden;

    Lund Univ Div Oncol &

    Pathol Dept Clin Sci Lund Sweden;

    Univ Copenhagen Biotech Res &

    Innovat Ctr Copenhagen Denmark;

    Lund Univ Div Mol Hematol Dept Lab Med Lund Stem Cell Ctr Fac Med Lund Sweden;

    Karolinska Inst Dept Med Ctr Hematol &

    Regenerat Med Stockholm Sweden;

    Univ Washington Fred Hutchinson Canc Res Ctr Div Human Biol Dept Med Seattle WA 98195 USA;

    Lund Univ Div Mol Hematol Dept Lab Med Lund Stem Cell Ctr Fac Med Lund Sweden;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 细胞生物学;
  • 关键词

  • 入库时间 2022-08-19 23:27:51

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号